Literature DB >> 7692197

Persistence of HCV despite antibodies to both putative envelope glycoproteins.

D Y Chien, Q L Choo, R Ralston, R Spaete, M Tong, M Houghton, G Kuo.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 7692197     DOI： 10.1016/0140-6736(93)91983-s

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  20 in total

1.  Use of a novel hepatitis C virus (HCV) major-epitope chimeric polypeptide for diagnosis of HCV infection.

Authors:  D Y Chien; P Arcangel; A Medina-Selby; D Coit; M Baumeister; S Nguyen; C George-Nascimento; A Gyenes; G Kuo; P Valenzuela
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 2.  Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine design.

Authors:  Leopold Kong; Kelli N Jackson; Ian A Wilson; Mansun Law
Journal:  Curr Opin Virol       Date:  2015-04-29       Impact factor: 7.090

Review 3.  Immunodiagnosis of viral hepatitides A to E and non-A to -E.

Authors:  G Yang; G N Vyas
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

4.  Design of novel conformational and genotype-specific antigens for improving sensitivity of immunoassays for hepatitis C virus-specific antibodies.

Authors:  Sansan Lin; Phillip Arcangel; Angelica Medina-Selby; Doris Coit; Philip Ng; Steve Nguyen; Colin McCoin; Alex Gyenes; Celine Hu; Laura Tandeske; Bruce Phelps; David Chien
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Evidence for prostaglandin-producing supressor cells in HCV patients with normal ALT.

Authors:  Rui Marinho; Ruth Pinto; Maria Livia Santos; MouraMiguelCarneiro de
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

6.  Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype.

Authors:  R B Ray; L M Lagging; K Meyer; R Ray
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor.

Authors:  M Matsumoto; T Y Hsieh; N Zhu; T VanArsdale; S B Hwang; K S Jeng; A E Gorbalenya; S Y Lo; J H Ou; C F Ware; M M Lai
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

8.  Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus.

Authors:  R Ray; A Khanna; L M Lagging; K Meyer; Q L Choo; R Ralston; M Houghton; P R Becherer
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees.

Authors:  S E Bassett; D L Thomas; K M Brasky; R E Lanford
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Vaccination of chimpanzees against infection by the hepatitis C virus.

Authors:  Q L Choo; G Kuo; R Ralston; A Weiner; D Chien; G Van Nest; J Han; K Berger; K Thudium; C Kuo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.